Baolingbao Biology Co Ltd Net Asset Quality Index

Latest as of March 2026: 78.6%

Baolingbao Biology Co Ltd net asset quality index. Baolingbao Biology Co Ltd (002286) has a Net Asset Quality Index of 78.6% as of March 2026. This metric measures the proportion of total assets financed by shareholders' equity — total assets of CN¥2.93 Billion minus total liabilities of CN¥625.57 Million yields net assets of CN¥2.30 Billion. A higher index indicates a stronger, lower-leverage balance sheet. See 002286 net asset value for net asset value and shareholders' equity analysis.

Quality Index

78.6%
Equity / Total Assets

Net Assets

CN¥2.30 Billion
CNY

Total Assets

CN¥2.93 Billion
CNY

Total Liabilities

CN¥625.57 Million
CNY

Net Asset Quality Index of Baolingbao Biology Co Ltd (2006–2025)

Net asset quality index of Baolingbao Biology Co Ltd from 2006 to 2025. This chart shows how Baolingbao Biology Co Ltd's Net Asset Quality Index has evolved across 20 annual periods from 2006 to 2025. As of March 2026, the index stands at 78.6%, representing net assets of CN¥2.30 Billion against total assets of CN¥2.93 Billion CNY. Check 002286 strategic asset allocation to assess the company's strategic physical and investment asset allocation.

Baolingbao Biology Co Ltd Net Asset Quality Index by Year (2006–2025)

Baolingbao Biology Co Ltd net asset quality index by year from 2006 to 2025. The table below presents the year-by-year Net Asset Quality Index for Baolingbao Biology Co Ltd from 2006 to 2025, covering 20 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Baolingbao Biology Co Ltd stock valuation.

Year Quality Index Net Assets (CNY) Total Assets Total Liabilities Change (pp)
2025 80.3% CN¥2.23 Billion CN¥2.78 Billion CN¥547.81 Million ▲ +4.0 pp
2024 76.3% CN¥2.04 Billion CN¥2.67 Billion CN¥632.44 Million ▲ +1.8 pp
2023 74.6% CN¥1.98 Billion CN¥2.66 Billion CN¥675.41 Million ▲ +7.9 pp
2022 66.7% CN¥2.00 Billion CN¥3.01 Billion CN¥1.00 Billion ▲ +6.8 pp
2021 59.9% CN¥1.81 Billion CN¥3.03 Billion CN¥1.22 Billion ▼ -1.3 pp
2020 61.1% CN¥1.60 Billion CN¥2.62 Billion CN¥1.02 Billion ▼ -1.1 pp
2019 62.2% CN¥1.57 Billion CN¥2.52 Billion CN¥951.76 Million ▲ +2.4 pp
2018 59.8% CN¥1.54 Billion CN¥2.58 Billion CN¥1.04 Billion ▼ -12.6 pp
2017 72.4% CN¥1.53 Billion CN¥2.11 Billion CN¥581.79 Million ▼ -5.7 pp
2016 78.1% CN¥1.51 Billion CN¥1.93 Billion CN¥423.43 Million ▲ +0.8 pp
2015 77.2% CN¥1.48 Billion CN¥1.91 Billion CN¥435.44 Million ▼ -4.8 pp
2014 82.1% CN¥1.45 Billion CN¥1.77 Billion CN¥316.69 Million ▼ -3.6 pp
2013 85.6% CN¥1.44 Billion CN¥1.68 Billion CN¥240.88 Million ▲ +12.2 pp
2012 73.5% CN¥817.45 Million CN¥1.11 Billion CN¥295.31 Million ▲ +5.1 pp
2011 68.4% CN¥760.53 Million CN¥1.11 Billion CN¥352.06 Million ▲ +0.3 pp
2010 68.1% CN¥703.11 Million CN¥1.03 Billion CN¥329.46 Million ▲ +7.0 pp
2009 61.1% CN¥662.61 Million CN¥1.08 Billion CN¥421.50 Million ▲ +29.1 pp
2008 32.0% CN¥238.05 Million CN¥743.91 Million CN¥505.85 Million ▼ -0.1 pp
2007 32.1% CN¥193.28 Million CN¥601.90 Million CN¥408.62 Million ▲ +10.0 pp
2006 22.2% CN¥112.53 Million CN¥507.93 Million CN¥395.40 Million —
pp = percentage points